These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6735274

  • 21. [Hirudin inhibition of human thrombin activity].
    Ascenzi P, Bolognesi M, Coletta M, Menegatti E, Amiconi G.
    Medicina (Firenze); 1990; 10(4):391-2. PubMed ID: 2099980
    [Abstract] [Full Text] [Related]

  • 22. Thrombin inhibition by covalently bound hirudin.
    Ito RK, Phaneuf MD, LoGerfo FW.
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):77-81. PubMed ID: 1773001
    [Abstract] [Full Text] [Related]

  • 23. Kinetics of the inhibition of thrombin by hirudin.
    Stone SR, Hofsteenge J.
    Biochemistry; 1986 Aug 12; 25(16):4622-8. PubMed ID: 3768302
    [Abstract] [Full Text] [Related]

  • 24. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R.
    Haemostasis; 1991 Aug 12; 21 Suppl 1():41-8. PubMed ID: 1894196
    [Abstract] [Full Text] [Related]

  • 25. Hirudin for diagnostic purposes.
    Stocker K.
    Haemostasis; 1991 Aug 12; 21 Suppl 1():161-7. PubMed ID: 1894191
    [Abstract] [Full Text] [Related]

  • 26. Surface modification with PEG and hirudin for protein resistance and thrombin neutralization in blood contact.
    Alibeik S, Zhu S, Brash JL.
    Colloids Surf B Biointerfaces; 2010 Dec 01; 81(2):389-96. PubMed ID: 20709502
    [Abstract] [Full Text] [Related]

  • 27. Contribution of the N-terminal region of hirudin to its interaction with thrombin.
    Wallace A, Dennis S, Hofsteenge J, Stone SR.
    Biochemistry; 1989 Dec 26; 28(26):10079-84. PubMed ID: 2620063
    [Abstract] [Full Text] [Related]

  • 28. Enhanced effect of inhibition of thrombin on endothelium in murine endotoxaemia: specific inhibition of thrombocytopenia.
    Chen D, McVey JH, Dorling A.
    Thromb Res; 2013 Dec 26; 132(6):750-6. PubMed ID: 24161661
    [Abstract] [Full Text] [Related]

  • 29. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
    Pearson JM, Schultze AE, Schwartz KA, Scott MA, Davis JM, Roth RA.
    J Pharmacol Exp Ther; 1996 Jul 26; 278(1):378-83. PubMed ID: 8764373
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the fate of platelet-bound thrombin.
    Yeo KT, Detwiler TC.
    Arch Biochem Biophys; 1985 Jan 26; 236(1):399-410. PubMed ID: 3917649
    [Abstract] [Full Text] [Related]

  • 31. Hirudin--a potential stabilizing factor for platelet preservation in transfusion.
    Pindur G, Wenzel E, Koehler M, Heiden M, Braun B.
    Haemostasis; 1991 Jan 26; 21 Suppl 1():156-60. PubMed ID: 1832654
    [Abstract] [Full Text] [Related]

  • 32. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E, Hoffmann A, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Jan 26; 109(1):98-106. PubMed ID: 6177615
    [Abstract] [Full Text] [Related]

  • 33. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
    Kobsar A, Koessler J, Kehrer L, Gambaryan S, Walter U.
    Thromb Haemost; 2012 Mar 26; 107(3):521-9. PubMed ID: 22234363
    [Abstract] [Full Text] [Related]

  • 34. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.
    Hoffmann H, Siebeck M, Spannagl M, Weis M, Geiger R, Jochum M, Fritz H.
    Am Rev Respir Dis; 1990 Oct 26; 142(4):782-8. PubMed ID: 2221583
    [Abstract] [Full Text] [Related]

  • 35. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP.
    Am J Physiol; 1988 Dec 26; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [Abstract] [Full Text] [Related]

  • 36. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
    Huang Y, Zhang Y, Zhao B, Xu Q, Zhou X, Song H, Yu M, Mo W.
    BMC Struct Biol; 2014 Dec 20; 14():26. PubMed ID: 25526801
    [Abstract] [Full Text] [Related]

  • 37. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J, Brüggener E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Dec 20; 115(1-2):83-7. PubMed ID: 2459037
    [Abstract] [Full Text] [Related]

  • 38. [Biochemical and pharmacological aspects of the thrombin inhibitor hirudin].
    Walsmann P, Markwardt F.
    Pharmazie; 1981 Oct 20; 36(10):653-60. PubMed ID: 7031705
    [No Abstract] [Full Text] [Related]

  • 39. Platelets adhere to thrombin-treated endothelial cells in vitro.
    Kaplan JE, Moon DG, Weston LK, Minnear FL, Del Vecchio PJ, Shepard JM, Fenton JW.
    Am J Physiol; 1989 Aug 20; 257(2 Pt 2):H423-33. PubMed ID: 2764129
    [Abstract] [Full Text] [Related]

  • 40. Effects of hirudin (thrombin specific inhibitor) in zebrafish embryos: a developmental role for thrombin.
    Jagadeeswaran P, Liu YC, Eddy CA.
    Blood Cells Mol Dis; 1997 Dec 20; 23(3):410-4. PubMed ID: 9446755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.